Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General

Microsoft And Viasat Announce Collaboration Through Microsoft Airband Initiative

By Bill Haddad
December 14, 9:07 AM
REDMOND, Wash., Dec. 14, 2022 /PRNewswire/ -- On Wednesday, Microsoft Corp. (NASDAQ:MSFT) and Viasat (NASDAQ:VSAT) announced a new partnership to help deliver internet access to 10 million people

MSFT

Read More
1 minute read
  • Biotech
  • General

Urica Therapeutics Expands Exclusive License Agreement With Fuji Yakuhin Co. Ltd. To Develop Dotinurad In Additional Territories Including Turkey, Middle East And North Africa

By Bill Haddad
December 14, 9:01 AM
Urica Therapeutics, Inc. ("Urica" or the "Company") (formerly known as UR-1 Therapeutics, Inc.), a Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress") subsidiary company focused on the

FBIO

Read More
1 minute read
  • Biotech
  • General

Kymera Announces Results From Phase 1 Clinical Trial Evaluating KT-474 In Patients With HS And AD And Sanofi’s Decision To Advance KT-474 Into Phase 2 Clinical Trials

By Bill Haddad
December 14, 8:12 AM
KT-474 Phase 1 clinical data in HS and AD patients demonstrate robust IRAK4 knockdown in blood and active skin lesions and systemic suppression of proinflammatory cytokines and chemokines with a favorable safety

KYMR

Read More
1 minute read
  • Biotech
  • General

Avidity Announces AOC 1001 Phase 1/2 MARINA Data Demonstrating Successful Targeted Delivery Of RNA to Muscle

By Bill Haddad
December 14, 8:08 AM
AOC 1001 delivered siRNA to skeletal muscle and produced meaningful DMPK reduction in 100% of participants with a 45% mean reduction in DMPK after a single dose of 1 mg/kg or two doses of 2 mg/kg AOC

RNA

Read More
1 minute read
  • Cryptocurrency
  • Markets

Germany Calls For Global Regulation Of Crypto Industry

By Bill Haddad
December 14, 7:29 AM
-Bloomberg

BTC

Read More
1 minute read
  • Biotech
  • General

Icosavax Provides Six-Month Update From Phase 1/1b Trial Of IVX-121

By Bill Haddad
December 13, 5:09 PM
- In new data from Phase 1/1b study, IVX-121 showed sustained immunologic response at six months; geometric mean titers (GMT) against RSV-A through day 180 persisting at 64-98% of the GMTs at day 28 in older

ICVX

Read More
1 minute read
  • Biotech
  • General

Pfizer Says Actively Collaborating With All Stakeholders To Secure An Adequate Supply Of Covid Drug Paxlovid In China

By Bill Haddad
December 13, 2:03 PM
-Reuters

PFE

Read More
1 minute read
  • M&A

Midatech Pharma: Deal To Be Satisfied By Issue Of 75.9M New Shares Of 0.1P Each In Co Capital At Exchange Ratio Of 0.9556 Shares For Each Bioasis Share

By Bill Haddad
December 13, 11:26 AM
-Reuters

MTP

Read More
1 minute read
  • General
  • Global
  • News
  • Politics

Russian Deputy Foreign Minister: Russia And US To Continue Talks On Points Of Contention In New Year

By Bill Haddad
December 13, 11:21 AM
-Russian State Media

RSX

Read More
1 minute read
  • Earnings
  • News

Rafael Holdings Q1 EPS $(0.22) Up From $(0.75) YoY

By Bill Haddad
December 13, 8:07 AM
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.22) per share. This is a 70.67 percent increase over losses of $(0.75) per share from the same period last year.

RFL

Posts pagination

Previous 1 … 33 34 35 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service